Case-control Study of Methylenetetrahydrofolate Reductase Mutations and Hyperhomocysteinemia and Risk of Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 5, 2009, Pages 407-408

  Almawi, Wassim Y ^a   Khan, Abdulmajeed ^b   Al Othman, Sara S ^a   Bakhiet, Moiz ^a,b  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b Department of Pathology   (Bahrain)

Author keywords

homocysteine; methylenetetrahydrofolate reductase; Stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID SUBSTITUTION; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PATIENT INFORMATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STROKE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; RISK FACTORS; STROKE; UP-REGULATION;

EID: 69149092062     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.12.003     Document Type: Article

References (10)

1. Humphries S.E., and Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: Insights into pathophysiology from candidate gene approaches. Lancet Neurol 3 (2004) 227-235
2. Kim R.J., and Becker R.C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: A meta-analysis of published studies. Am Heart J 146 (2003) 948-957
3. Eskandari M.K., Bontempo F.A., Hassett A.C., et al. Arterial thromboembolic events in patients with the factor V Leiden mutation. Am J Surg 176 (1998) 122-125
4. Perry I.J., Refsum H., Morris R.W., et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346 (1995) 1395-1398
5. Li Z., Sun L., Zhang H., et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: A multicenter case-control study in China. Stroke 34 (2003) 2085-2090
6. Verhoef P., Hennekens C.H., Malinow M.R., et al. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25 (1994) 1924-1930
7. Lopaciuk S., Bykowska K., Kwiecinski H., et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydro-folate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 7 (2001) 346-350
8. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1208
9. Weisberg I.S., Jacques P.F., Selhub J., et al. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): In vitro expression and association with homocysteine. Atherosclerosis 156 (2001) 409-415
10. Fryer R.H., Wilson B.D., Gubler D.B., et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 13 (1993) 1327-1333